Takeda’s Dengue Vaccine Gets Its 1st Approval in Indonesia

August 24, 2022
Takeda Pharmaceutical said on August 22 that its live-attenuated tetravalent dengue vaccine Qdenga, previously known as TAK-003, has won its first approval in the world in Indonesia. It is the company’s first jab marketed outside of Japan. The Indonesia National...read more